Section I
11 – 20 of 4700
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
2024) European Association for Cancer Research(
- Contribution to conference › Poster
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change
2024) In International Journal of Cancer(
- Contribution to journal › Article
-
Mark
Impact of type 2 diabetes on complications after primary breast cancer surgery : Danish population-based cohort study
(
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE) : Protocol for a Translational Study
(
- Contribution to journal › Article
-
Mark
Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer
(
- Contribution to journal › Article
-
Mark
Population pharmacokinetic–pharmacodynamic model of subcutaneous bupivacaine in a novel extended-release microparticle formulation
2024) In Basic and Clinical Pharmacology and Toxicology(
- Contribution to journal › Article